Correlation Between Dupont De and Humacyte
Can any of the company-specific risk be diversified away by investing in both Dupont De and Humacyte at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dupont De and Humacyte into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dupont De Nemours and Humacyte, you can compare the effects of market volatilities on Dupont De and Humacyte and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dupont De with a short position of Humacyte. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dupont De and Humacyte.
Diversification Opportunities for Dupont De and Humacyte
Very good diversification
The 3 months correlation between Dupont and Humacyte is -0.27. Overlapping area represents the amount of risk that can be diversified away by holding Dupont De Nemours and Humacyte in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Humacyte and Dupont De is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dupont De Nemours are associated (or correlated) with Humacyte. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Humacyte has no effect on the direction of Dupont De i.e., Dupont De and Humacyte go up and down completely randomly.
Pair Corralation between Dupont De and Humacyte
Allowing for the 90-day total investment horizon Dupont De Nemours is expected to generate 0.81 times more return on investment than Humacyte. However, Dupont De Nemours is 1.24 times less risky than Humacyte. It trades about 0.13 of its potential returns per unit of risk. Humacyte is currently generating about -0.32 per unit of risk. If you would invest 7,846 in Dupont De Nemours on November 22, 2024 and sell it today you would earn a total of 396.00 from holding Dupont De Nemours or generate 5.05% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Dupont De Nemours vs. Humacyte
Performance |
| Timeline |
| Dupont De Nemours |
| Humacyte |
Dupont De and Humacyte Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Dupont De and Humacyte
The main advantage of trading using opposite Dupont De and Humacyte positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dupont De position performs unexpectedly, Humacyte can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Humacyte will offset losses from the drop in Humacyte's long position.| Dupont De vs. Eastman Chemical | Dupont De vs. Olin Corporation | Dupont De vs. Cabot | Dupont De vs. Kronos Worldwide |
| Humacyte vs. Crinetics Pharmaceuticals | Humacyte vs. Viridian Therapeutics | Humacyte vs. Cytokinetics | Humacyte vs. Structure Therapeutics American |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Other Complementary Tools
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |